The Ocular

Chaperone Company

 
Our TechnologyOur_Technology.html
Contact UsContact_Us.html

BIKAM Pharmaceuticals is a small venture-backed company, focused on the discovery and development of novel drugs for degenerative diseases of the eye.  The BIKAM approach uses a new, increasingly important, molecular approach to therapy that has shown real promise for medical opportunity in other therapeutic areas.  The company is working to discover and develop pharmacologic chaperones specific for misfolded proteins within the retina that lead to serious retinal degenerative disease and blindness.  Currently, the company’s lead program in Retinitis Pigmentosa is at the stage of Clinical Candidate.

About UsAbout_Us.html